376 related articles for article (PubMed ID: 16649836)
1. A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.
Vieta E; Manuel Goikolea J; Martínez-Arán A; Comes M; Verger K; Masramon X; Sanchez-Moreno J; Colom F
J Clin Psychiatry; 2006 Mar; 67(3):473-7. PubMed ID: 16649836
[TBL] [Abstract][Full Text] [Related]
2. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.
Pande AC; Crockatt JG; Janney CA; Werth JL; Tsaroucha G
Bipolar Disord; 2000 Sep; 2(3 Pt 2):249-55. PubMed ID: 11249802
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
Weisler RH; Kalali AH; Ketter TA;
J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
[TBL] [Abstract][Full Text] [Related]
5. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
6. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
7. Gabapentin treatment of the non-refractory bipolar spectrum: an open case series.
Ghaemi SN; Goodwin FK
J Affect Disord; 2001 Jul; 65(2):167-71. PubMed ID: 11356240
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
Vieta E; Cruz N; García-Campayo J; de Arce R; Manuel Crespo J; Vallès V; Pérez-Blanco J; Roca E; Manuel Olivares J; Moríñigo A; Fernández-Villamor R; Comes M
Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?
Perugi G; Toni C; Frare F; Ruffolo G; Moretti L; Torti C; Akiskal HS
J Clin Psychopharmacol; 2002 Dec; 22(6):584-91. PubMed ID: 12454558
[TBL] [Abstract][Full Text] [Related]
10. Topiramate as add-on treatment for patients with bipolar mania.
Chengappa KN; Rathore D; Levine J; Atzert R; Solai L; Parepally H; Levin H; Moffa N; Delaney J; Brar JS
Bipolar Disord; 1999 Sep; 1(1):42-53. PubMed ID: 11256656
[TBL] [Abstract][Full Text] [Related]
11. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
Weisler RH; Keck PE; Swann AC; Cutler AJ; Ketter TA; Kalali AH;
J Clin Psychiatry; 2005 Mar; 66(3):323-30. PubMed ID: 15766298
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study.
Cabras PL; Hardoy MJ; Hardoy MC; Carta MG
J Clin Psychiatry; 1999 Apr; 60(4):245-8. PubMed ID: 10221286
[TBL] [Abstract][Full Text] [Related]
14. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
[TBL] [Abstract][Full Text] [Related]
15. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive treatment with gabapentin in bipolar patients during acute mania.
Astaneh AN; Rezaei O
Int J Psychiatry Med; 2012; 43(3):261-71. PubMed ID: 22978083
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin in the treatment of adolescent mania: a case report.
Soutullo CA; Casuto LS; Keck PE
J Child Adolesc Psychopharmacol; 1998; 8(1):81-5. PubMed ID: 9639083
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
Calabrese JR; Keck PE; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
J Clin Psychiatry; 2015 Mar; 76(3):284-92. PubMed ID: 25562205
[TBL] [Abstract][Full Text] [Related]
20. Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized Clinical Trial.
Mowla A; Ahmadzadeh L; Razeghian Jahromi L; Dastgheib SA
Clin Drug Investig; 2015 Aug; 35(8):513-7. PubMed ID: 26123629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
